Fu-zheng-qu-zhuo Oral Liquid Combined With Integrated Therapy Improves Renal Function in Patients of Chronic Kidney Disease Stage 3 and 4，a Randomized Placebo-Control Clinical Trial

NCT02275468 Phase 2 COMPLETED

a prospective, multicenter (outpatient clinics of the three participating hospitals in Beijing), double blinded and randomized placebo-controlled study. The study consisted of a 2-week run-in period and a 12-month treatment period.

Details

Lead sponsor	Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Phase	Phase 2
Status	COMPLETED
Enrolment	124
Start date	2010-06
Completion	2014-10

Conditions

• Stage 3 Chronic Kidney Disease
• Stage 4 Chronic Kidney Disease

Interventions

• Fu-zheng-qu-zhuo (FZQZ) oral liquid

Primary outcomes

• composite end point — 12 month after the treatmnet and 3 years of the follow up time
  end stage renal disease (defined by the need for long-term dialysis or renal transplantation, or eGFR\<15ml/min) and all cause of death

Countries

China